Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Abstract Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in Afric...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Cesar A.Romero, Shobi Mathew, Benjamin Wasinski, Brian Reed, Aaron Brody, Rachelle Dawood, Michael J. Twiner, Candace D. McNaughton, Rafael Fridman, John M. Flack, Oscar A. Carretero, Phillip D. Levy
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2021-05-01
Sarja:	The Journal of Clinical Hypertension
Aiheet:	ACE inhibitors Ac‐SDKP African American collagen left ventricular hypertrophy MMP‐1
Linkit:	https://doi.org/10.1111/jch.14206
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!